Glesatinib Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Glesatinib is a TKI that targets tumors with MET and AXL alterations.
Clinical Use
Nonclinical models have shown glesatinib to be effective in MET exon 14 skipping mutations. It is currently being evaluated in phase II trials in NSCLC patients with MET alterations.
Glesatinib Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte